• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Evogene Ltd Ord (NQ: EVGN )

    2.720 -0.081 (-2.88%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Oct 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 19,837
    Open 2.800
    Bid (Size) 2.720 (14)
    Ask (Size) 2.770 (1)
    Prev. Close 2.801
    Today's Range 2.662 - 2.810
    52wk Range 2.285 - 10.40
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    EVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024
    EVGN stock results show that Evogene missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024
    EVGN stock results show that Evogene beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -68.77%
    -68.77%
    1 Month
    -9.03%
    -9.03%
    3 Month
    -57.43%
    -57.43%
    6 Month
    -66.50%
    -66.50%
    1 Year
    -48.97%
    -48.97%

    More News

    Read More
    EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Israeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challenges
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Recap: Evogene Q3 Earnings
    Via Benzinga
    A Preview Of Evogene's Earnings
    Via Benzinga
    Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know
    Via Benzinga
    Earnings Outlook For Evogene
    Via Benzinga
    Earnings Scheduled For March 7, 2024
    Via Benzinga
    Evogene Earnings Preview
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023
    Via Benzinga
    Why Evogene Shares Are Moving
    Via Benzinga
    Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Why Evogene Stock Is Tanking Today
    Via Benzinga
    Evogene's Casterra Gets $2.2M Orders To Supply Castor Seeds
    Via Benzinga
    TalkMarkets Announces Company Spotlight Featuring Evogene
    Via Talk Markets
    Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    TalkMarkets Announces Company Spotlight Featuring Evogene
    Via TheNewswire.com
    TalkMarkets Announces Company Spotlight Featuring Evogene
    Via News Direct
    Evogene - A Company With Valuable Assets Trading At Zero Enterprise Value
    Via Talk Markets
    Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Evogene (EVGN) Stock Is Trading Higher
    Via Benzinga
    Tryp Submits IND Application To FDA For Clinical Trial Of Psilocybin-Assisted Psychotherapy In Patients With IBS
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.